Sysmex Europe GmbH: Clinical Trials

4 trials sponsored by Sysmex Europe GmbH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Recruiting 1

Follow Sysmex Europe GmbH: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
OSNA Versus Ultrastaging to Detect Sentinel Lymph Node Metastasis in Endometrial Cancer
OSNA, Ultrastaging - Endometrial Cancer
Not applicableRecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS19222025-07-302025-11-18
Clinical Impact Analysis of PA-100 AST in a Spanish GP Setting
PA-100 AST - UTI - Urinary Tract Infection, UTI - Lower Urinary Tract Infection
Not applicableCompletedSysmex Europe GmbH1992024-07-012025-09-24
Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region
None, treatment as actual best practice - Tropical Infectious Diseases
CompletedSysmex Europe GmbH9302016-04-012017-07-21
Hematological Infection Score Compared to the Hospital Standard for Diagnosis of SIRS or Sepsis on ICU
SIRS, Sepsis
CompletedCharite University, Berlin, Germany2072010-03-012012-01-05

Conditions studied

Disease (1)  ·  Endometrial Neoplasms (1)  ·  Sepsis (1)  ·  Urinary Tract Infections (1)

Interventions

Therapeutics (1)

Countries

Burkina Faso (1)  ·  Germany (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Andre van der Ven (1)  ·  Claudia Spies, MD Prof. (1)  ·  Francesco Fanfani, Professor (1)  ·  Halidou Tinto (1)  ·  Jan Jacobs (1)  ·  Jose Medina Polo (1)

Results publications

PMID 31146732, PMID 33253198, PMID 33647009, PMID 35418154, PMID 41794557